ICR Healthcare and Sponsors 13th Annual Healthcare Conference
12pm – 6:30pm
Monday 17th November 2025
De Vere Grand Connaught Rooms
61-65 Great Queen St, London WC2B 5DA
Confirmed Panelists
Rob Lyne
CEO
Puretech Health
Riad Sherif
CEO
Oculis
Stefan Konig
CEO
Merz Therapeutics
Chris Hollowood
CEO
Syncona Investment Management
Henriette Wennicke
CFO
Zealand Pharma
Pierre Kemula
CFO
Agomab
Richard Taylor
Executive Director
MSD
Hannah Kuchler
Global Pharmaceutical Editor
Financial Times
Alethia Young
CFO
Bicycle Therapeutics
James Lee
Senior Managing Director
Guggenheim Partners
Andrea Ponti
Founder and Managing Partner
GHO Capital
John Whittaker
Managing Director
Citi
Natalie Mount
CEO
Cytospire Therapeutics
Amit Shah
Principal
SR One
Svetlana Sigalova
CFO
Cosmo Healthcare
Renee Aguiar-Lucander
CEO
Hansa Biopharma
Tim Worden
Partner
Goodwin
Nick Riddle
Senior Managing Director
Guggenheim
Sophie McGrath
Partner
Goodwin
Yamin ‘ Mo’ Khan
Chief Executive Officer
hVIVO
Agenda
| Time | Panel Name |
| 12:00-13.00 | Lunch and networking |
| 13.00-13.05 | Introduction from Amber Fennell, Senior Partner, ICR Healthcare |
| 13:05-13:50 | FIRESIDE CHAT: A discussion with Renee Aguiar-Lucander, Hansa Biopharma Panelists: Renee Aguiar-Lucander, Chief Executive Officer, Hansa Biopharma Hannah Kuchler, Global Pharmaceutical Editor, Financial Times [Interviewer] |
| 13:50-14:35 | PANEL 1: Brave New World: When uncertainty is the order of the day, how do healthcare leaders support stability while providing direction? Panelists: Jessica Hodgson, Partner, ICR Healthcare [Moderator] Yamin ‘Mo’ Khan, Chief Executive Officer, hVIVO Riad Sherif, Chief Executive Officer, Oculis Stefan König, Chief Executive Officer, Merz Therapeutics Robert Lyne, Chief Executive Officer, PureTech Health Svetlana Sigalova, Chief Financial Officer, Cosmo Healthcare |
| 14:35-15:20 | Break |
| 15:20-16:05 | PANEL 2: Brave Finance: Smart finance approaches for public and private companies Panelists: Nick Riddle, Senior Managing Director, Guggenhiem [Moderator] Chris Hollowood, Chief Executive Officer, Syncona Investment Management Andrea Ponti, Founder and Managing Partner, GHO Capital Henriette Wennicke, Chief Financial Officer, Zealand Pharma Alethia Young, Chief Financial Officer, Bicycle Therapeutics James Lee, Senior Managing Director, Guggenheim Pierre Kemula, Chief Financial Officer, Agomab |
| 16:05-16:50 | CASE STUDY: Choosing the next move – finding a path between M&A and licensing Panelists: Sophie McGrarth, Partner, Goodwin [Moderator] Richard Taylor, Executive Director, MSD Natalie Mount, Chief Executive Officer, Cytospire Therapeutics Amit Shah, Principal, SR One Tim Worden, Partner, Goodwin John Whittaker, Managing Director, Citi |
| 16:50-17:00 | Closing remarks from Mary-Jane Elliott, Managing Partner, ICR Healthcare |
| 17:00-18:30 | Networking drinks |
Sponsored by:
Webcast by:
